A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons, finds that Medicare ...

Researchers have discovered that metabolic dysfunction-associated steatotic liver disease (MASLD) greatly increases the risk ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Boston Scientific reported Q2 2025 sales of over $5bn, a 22.8% rise on Q2 2024, besting previous growth estimates of 19.5% at ...

The company now expects a tariff charge of $100 million this year, down from a $200 million impact forecast on the company’s ...

In a new study from Uppsala University in Sweden, researchers found that just three nights of restricted sleep – around four ...

Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S.

Boston Scientific bumped up its financial forecasts for the remainder of this year, after reporting double-digit growth ...

Mark Cuban says AI could unlock trillionaire status for the right innovator. Find out what it takes—and how you could be part ...

The medical device manufacturer expects 2025 adjusted profit of $2.95 to $2.99 per share, up from the prior view of $2.87 to ...